Anders Hugander

1.8k total citations
48 papers, 1.4k citations indexed

About

Anders Hugander is a scholar working on Oncology, Immunology and Biomedical Engineering. According to data from OpenAlex, Anders Hugander has authored 48 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 15 papers in Immunology and 15 papers in Biomedical Engineering. Recurrent topics in Anders Hugander's work include Ultrasound and Hyperthermia Applications (12 papers), Immune Cell Function and Interaction (8 papers) and Chemokine receptors and signaling (7 papers). Anders Hugander is often cited by papers focused on Ultrasound and Hyperthermia Applications (12 papers), Immune Cell Function and Interaction (8 papers) and Chemokine receptors and signaling (7 papers). Anders Hugander collaborates with scholars based in Sweden, United States and Bahrain. Anders Hugander's co-authors include Roland E. Andersson, Anders Thulin, Gunnar Olaison, Jan Dimberg, Dick Wågsäter, Jan Dimberg, Peter Söderkvist, Sture Löfgren, Per Nyström and P O Nyström and has published in prestigious journals such as Cancer, Gut and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Anders Hugander

48 papers receiving 1.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Anders Hugander 640 601 323 194 174 48 1.4k
Thomas Foitzik 1.5k 2.3× 137 0.2× 1.0k 3.2× 251 1.3× 116 0.7× 71 2.0k
Walter Nußbaumer 291 0.5× 162 0.3× 263 0.8× 214 1.1× 353 2.0× 51 1.7k
Tamam Bakchoul 1.0k 1.6× 449 0.7× 99 0.3× 176 0.9× 255 1.5× 138 2.5k
Richard W. Kim 283 0.4× 172 0.3× 246 0.8× 579 3.0× 203 1.2× 25 1.6k
Thomas W. Frick 946 1.5× 177 0.3× 311 1.0× 80 0.4× 98 0.6× 58 1.3k
Jérémy Meyer 785 1.2× 75 0.1× 332 1.0× 214 1.1× 70 0.4× 112 1.3k
Patrizia Della Valle 337 0.5× 83 0.1× 132 0.4× 358 1.8× 170 1.0× 47 1.6k
Kathryn P. Clausen 234 0.4× 44 0.1× 396 1.2× 150 0.8× 172 1.0× 26 1.1k
Bernard Royer 358 0.6× 50 0.1× 241 0.7× 275 1.4× 172 1.0× 68 1.2k
Vassiliki L. Tsikitis 534 0.8× 100 0.2× 743 2.3× 277 1.4× 83 0.5× 92 1.6k

Countries citing papers authored by Anders Hugander

Since Specialization
Citations

This map shows the geographic impact of Anders Hugander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Hugander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Hugander more than expected).

Fields of papers citing papers by Anders Hugander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Hugander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Hugander. The network helps show where Anders Hugander may publish in the future.

Co-authorship network of co-authors of Anders Hugander

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Hugander. A scholar is included among the top collaborators of Anders Hugander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Hugander. Anders Hugander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dimberg, Jan, et al.. (2011). Expression of the serine protease inhibitor serpinA3 in human colorectal adenocarcinomas. Oncology Letters. 2(3). 413–418. 27 indexed citations
2.
Wågsäter, Dick, Sture Löfgren, Niklas Zar, Anders Hugander, & Jan Dimberg. (2010). Pigment Epithelium-Derived Factor Expression in Colorectal Cancer Patients. Cancer Investigation. 28(8). 872–877. 12 indexed citations
3.
Wågsäter, Dick, et al.. (2008). Resistin in Human Colorectal Cancer: Increased Expression Independently of Resistin Promoter −420C > G genotype. Cancer Investigation. 26(10). 1008–1014. 21 indexed citations
4.
Löfgren, Sture, et al.. (2008). Polymorphism in MHC class II transactivator gene is not associated with susceptibility to colorectal cancer in Swedish patients.. PubMed. 28(3B). 1789–91. 1 indexed citations
5.
Dimberg, Jan, Olaf Dienus, Sture Löfgren, Anders Hugander, & Dick Wågsäter. (2007). Polymorphisms of Fractalkine receptor CX3CR1 and plasma levels of its ligand CX3CL1 in colorectal cancer patients. International Journal of Colorectal Disease. 22(10). 1195–1200. 11 indexed citations
6.
Wågsäter, Dick, Sture Löfgren, Anders Hugander, Olaf Dienus, & Jan Dimberg. (2007). Analysis of single nucleotide polymorphism in the promoter and protein expression of the chemokine Eotaxin-1 in colorectal cancer patients. World Journal of Surgical Oncology. 5(1). 84–84. 25 indexed citations
7.
Dimberg, Jan, Anders Hugander, Sture Löfgren, & Dick Wågsäter. (2007). Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients. International Journal of Molecular Medicine. 19(1). 11–5. 37 indexed citations
8.
Wågsäter, Dick, et al.. (2005). Interleukin-1 receptor antagonist gene polymorphism in human colorectal cancer. Oncology Reports. 14(4). 915–8. 16 indexed citations
9.
Andersson, Roland E., Anders Hugander, Sam Ghazi, et al.. (1999). Diagnostic Value of Disease History, Clinical Presentation, and Inflammatory Parameters of Appendicitis. World Journal of Surgery. 23(2). 133–140. 131 indexed citations
10.
Dimberg, Jan, et al.. (1999). Differential expression of cyclooxygenase 2 in human colorectal cancer. Gut. 45(5). 730–732. 119 indexed citations
11.
Dimberg, Jan, et al.. (1998). Gene expression of cyclooxygenase-2, group II and cytosolic phospholipase A2 in human colorectal cancer.. PubMed. 18(5A). 3283–7. 36 indexed citations
12.
Andersson, Roland E., Anders Hugander, Anders Thulin, Per Nyström, & Gunnar Olaison. (1995). Clusters of Acute Appendicitis: Further Evidence for an Infectious Aetiology. International Journal of Epidemiology. 24(4). 829–833. 45 indexed citations
13.
Andersson, Roland E., Anders Hugander, Anders Thulin, P O Nyström, & Gunnar Olaison. (1994). Indications for operation in suspected appendicitis and incidence of perforation. BMJ. 308(6921). 107–110. 179 indexed citations
14.
Robins, H. Ian, et al.. (1991). Beta-blockade during whole-body hyperthermia: A toxicity study in the dog. International Journal of Hyperthermia. 7(2). 263–270. 4 indexed citations
15.
Hugander, Anders. (1990). Hyperthermia and the Liver. Advances in experimental medicine and biology. 267. 155–159. 3 indexed citations
16.
Hugander, Anders, et al.. (1988). Design and test of microwave interstitial applicators with improved longitudinal heating pattern. International Journal of Hyperthermia. 4(6). 609–615. 6 indexed citations
17.
Hugander, Anders, H. Ian Robins, Patricia Martín, & Colleen M. Schmitt. (1987). Temperature distribution during radiant heat whole-body hyperthermia: Experimental studies in the dog. International Journal of Hyperthermia. 3(3). 199–208. 17 indexed citations
18.
Hugander, Anders, et al.. (1985). Effects of local microwave hyperthermia and 5-fluorouracil in treatment of experimental liver cancer.. PubMed. 5(3). 281–5. 1 indexed citations
19.
Hafström, L, et al.. (1982). Experimental set-up for studies of microwave-induced hyperthermia in rats. Physics in Medicine and Biology. 27(3). 397–406. 7 indexed citations
20.
Bauer, H., et al.. (1980). [Angiodysplasia--a common cause of rectal bleeding].. PubMed. 77(17). 1632–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Foitzik Breakdown of academic impact, for papers by Walter Nußbaumer Breakdown of academic impact, for papers by Tamam Bakchoul Breakdown of academic impact, for papers by Richard W. Kim Breakdown of academic impact, for papers by Thomas W. Frick Breakdown of academic impact, for papers by Jérémy Meyer Breakdown of academic impact, for papers by Patrizia Della Valle Breakdown of academic impact, for papers by Kathryn P. Clausen Breakdown of academic impact, for papers by Bernard Royer Breakdown of academic impact, for papers by Vassiliki L. Tsikitis
Rankless by CCL
2026